• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用直接压片法和响应面法研制并优化左旋多巴和苯甲肼口腔崩解片。

Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.

机构信息

State Key Laboratory Base for Eco-Chemical Engineering in College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China.

Department of Pharmaceutical Engineering, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, China.

出版信息

Drug Dev Ind Pharm. 2020 Jan;46(1):42-49. doi: 10.1080/03639045.2019.1698597. Epub 2020 Jan 20.

DOI:10.1080/03639045.2019.1698597
PMID:31794271
Abstract

The number of Parkinson's disease (PD) patients with the advanced phase and motor fluctuations is increasing. The objective of this study is developing levodopa/benzylhydrazine orally disintegrating tablets (L/B ODTs), which would provide greater convenience and ease of use than conventional tablets for these patients. In the present study, the L/B ODTs were developed successfully with an optimized formulation using response surface methodology (RSM). The direct compression technology was employed for the preparation of L/B ODTs. Considerably shorter disintegration time and faster dissolution profile were obtained under the optimum formulation with microcrystalline cellulose 25.7%, cross-polyvinylpyrrolidone 6.22% and Sodium carboxymethyl starch 5.36%. The content uniformity (%) of levodopa and benzylhydrazine was 50 ± 1.4% and 14.25 ± 0.6%, respectively. Thickness, friability, hardness and wetting time were 2.8 ± 0.05 mm, 0.46 ± 0.21%, 5.42 ± 1.1 kp and 31.2 ± 2.1 s, respectively, and all of data well comply with the General Principles of the Chinese Pharmacopeia. Mannitol of 22% in formulation could bring a pleasant taste: sweet, cool and refreshing. Almost all the volunteers felt that the ODTs had good taste, no roughness, and no gritty feeling, indicating that the ODTs prepared had good palatability, so patients will have good compliance when taking medicine.

摘要

帕金森病(PD)晚期和运动波动的患者人数正在增加。本研究的目的是开发左旋多巴/苯肼口腔崩解片(L/B ODT),与常规片剂相比,为这些患者提供更大的便利性和易用性。在本研究中,使用响应面法(RSM)成功开发了优化配方的 L/B ODT。采用直接压片技术制备 L/B ODT。在含有微晶纤维素 25.7%、交联聚维酮 6.22%和羧甲基淀粉钠 5.36%的最佳配方下,崩解时间显著缩短,溶解速度更快。左旋多巴和苯肼的含量均匀度(%)分别为 50±1.4%和 14.25±0.6%。厚度、脆碎度、硬度和润湿时间分别为 2.8±0.05mm、0.46±0.21%、5.42±1.1kp 和 31.2±2.1s,所有数据均符合《中国药典》通则要求。配方中 22%的甘露醇可带来宜人的口感:甜、凉、清爽。几乎所有志愿者都觉得 ODT 口感良好,无粗糙感,无沙砾感,说明所制备的 ODT 具有良好的适口性,因此患者在服药时会有良好的依从性。

相似文献

1
Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology.采用直接压片法和响应面法研制并优化左旋多巴和苯甲肼口腔崩解片。
Drug Dev Ind Pharm. 2020 Jan;46(1):42-49. doi: 10.1080/03639045.2019.1698597. Epub 2020 Jan 20.
2
A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.一种新颖且具有区分度的体外崩解时间方法,用于马来酸卡比沙明掩味口腔崩解片的制备和优化。
Drug Dev Ind Pharm. 2018 Aug;44(8):1317-1327. doi: 10.1080/03639045.2018.1449854. Epub 2018 Mar 22.
3
Computer-aided optimization of carbidopa/levodopa orally disintegrating tablets.计算机辅助优化卡比多巴/左旋多巴口腔崩解片。
Drug Dev Ind Pharm. 2024 Apr;50(4):331-340. doi: 10.1080/03639045.2024.2327475. Epub 2024 Mar 19.
4
Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.采用共处理赋形剂的巴氯芬-美洛昔康口崩片(ODTs)的配方和评价以及使用六西格玛方法改善 ODTs 性能。
Drug Des Devel Ther. 2021 Oct 16;15:4383-4402. doi: 10.2147/DDDT.S327193. eCollection 2021.
5
Further improvement of orally disintegrating tablets using micronized ethylcellulose.进一步使用微粉化乙基纤维素改善口崩片。
Int J Pharm. 2012 Feb 28;423(2):351-9. doi: 10.1016/j.ijpharm.2011.10.050. Epub 2011 Nov 26.
6
Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.盐酸克林霉素口腔崩解片的掩味技术开发与优化
Drug Dev Ind Pharm. 2015;41(7):1156-64. doi: 10.3109/03639045.2014.935392. Epub 2014 Jul 7.
7
A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.一项多中心、开放标签、序贯研究,比较帕金森病患者对卡比多巴-左旋多巴口腔崩解片和常规片剂的偏好。
Clin Ther. 2005 Jan;27(1):58-63. doi: 10.1016/j.clinthera.2005.01.004.
8
Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.右美沙芬氢溴酸盐口服分散片的研制与优化:处方和工艺变量的影响。
Pharm Dev Technol. 2013 Mar-Apr;18(2):454-63. doi: 10.3109/10837450.2012.710237. Epub 2012 Aug 13.
9
A new formulation for orally disintegrating tablets using a suspension spray-coating method.采用混悬液喷雾包衣法的新型口腔崩解片配方。
Int J Pharm. 2009 Dec 1;382(1-2):80-7. doi: 10.1016/j.ijpharm.2009.08.010. Epub 2009 Aug 15.
10
Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.微波辅助直接压片法制备口腔崩解片
AAPS PharmSciTech. 2017 Aug;18(6):2055-2066. doi: 10.1208/s12249-016-0683-z. Epub 2016 Dec 19.

引用本文的文献

1
Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.儿科用口腔崩解剂型:当前认知及基于纳米结构制剂的开发
Pharmaceutics. 2022 Aug 3;14(8):1621. doi: 10.3390/pharmaceutics14081621.
2
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma.德国来源的ONC201用于治疗H3K27M突变型弥漫性内生性脑桥胶质瘤的临床前和临床评估。
Neurooncol Adv. 2021 Nov 19;3(1):vdab169. doi: 10.1093/noajnl/vdab169. eCollection 2021 Jan-Dec.
3
Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.
口服速崩片(ODTs)的制剂与质量控制:最新进展与展望。
Biomed Res Int. 2021 Dec 24;2021:6618934. doi: 10.1155/2021/6618934. eCollection 2021.
4
Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs).口腔崩解片(ODTs)的最新剂型进展及治疗应用价值
Pharmacy (Basel). 2020 Oct 10;8(4):186. doi: 10.3390/pharmacy8040186.